Dr. Steven R. Savona
Overview
Steven Savona is a Hematologist and an Oncologist in Lake Success, New York. Dr. Savona is rated as an Experienced provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Malignant Peripheral Nerve Sheath Tumor, Bone Tumor, Melanoma, Thrombocytopenia, and Bone Marrow Aspiration.
His clinical research consists of co-authoring 5 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
450 Lakeville Road, Entrance B, Lake Success, NY 11042
Additional Areas of Focus
Dr. Savona has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Matthew Fury is an Oncologist in New York, New York. Dr. Fury is rated as an Advanced provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Basal Cell Skin Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), Tongue Cancer, and Cervical Cancer.
Memorial Solid Tumor Group
Charles Rudin is a Hematologist Oncology specialist and an Oncologist in New York, New York. Dr. Rudin is rated as an Elite provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Lung Adenocarcinoma, Non-Small Cell Lung Cancer (NSCLC), and Tissue Biopsy. Dr. Rudin is currently accepting new patients.
Icahn School Of Medicine At Mount Sinai
Philip Friedlander is an Oncologist in Fort Lee, New Jersey. Dr. Friedlander is rated as a Distinguished provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Squamous Cell Skin Carcinoma, Multiple Myeloma, and Thyroidectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Bone TumorDr. Savona isDistinguished. Learn about Bone Tumor.
- Malignant Peripheral Nerve Sheath TumorDr. Savona isDistinguished. Learn about Malignant Peripheral Nerve Sheath Tumor.
- Advanced
- AnemiaDr. Savona isAdvanced. Learn about Anemia.
- MelanomaDr. Savona isAdvanced. Learn about Melanoma.
- ThrombocytopeniaDr. Savona isAdvanced. Learn about Thrombocytopenia.
- Tongue CancerDr. Savona isAdvanced. Learn about Tongue Cancer.
- Experienced
- Acinic Cell Carcinoma of Salivary Glands
- Acute Lymphoblastic Leukemia (ALL)Dr. Savona isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Mountain SicknessDr. Savona isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Savona isExperienced. Learn about Acute Myeloid Leukemia (AML).